Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Jaejin An and Hui Zhou.
Connection Strength

1.047
  1. Incidence of Atherosclerotic Cardiovascular Disease in Young Adults at Low Short-Term But High Long-Term?Risk. J Am Coll Cardiol. 2023 Feb 21; 81(7):623-632.
    View in: PubMed
    Score: 0.221
  2. Risk of hospitalization and mortality associated with uncontrolled blood pressure in patients with hypertension and COVID-19. Int J Cardiol Cardiovasc Risk Prev. 2021 Dec; 11:200117.
    View in: PubMed
    Score: 0.202
  3. COVID-19 morbidity and mortality associated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers use among 14,129 patients with hypertension from a US integrated healthcare system. Int J Cardiol Hypertens. 2021 Jun; 9:100088.
    View in: PubMed
    Score: 0.196
  4. Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID-19 Infection Among 824 650 Patients With Hypertension From a US Integrated Healthcare System. J Am Heart Assoc. 2021 02 02; 10(3):e019669.
    View in: PubMed
    Score: 0.190
  5. Apparent treatment-resistant hypertension: characteristics and prevalence in a real-world environment of an integrated health system. J Hypertens. 2020 08; 38(8):1603-1611.
    View in: PubMed
    Score: 0.185
  6. Blood Pressure Control Among Black and White Adults Following a Quality Improvement Program in a Large Integrated Health System. JAMA Netw Open. 2023 01 03; 6(1):e2249930.
    View in: PubMed
    Score: 0.055

© 2024 Kaiser Permanente